KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...

Here are the top 5 most-read SAP articles in 2025. 5. With Remote Patient Monitoring, Picking Tools Is Easier Than Change ...

Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial ...

Semaglutide use is linked to fewer hospitalizations and fewer days in the hospital for patients with cardiovascular disease ...

Millions of Australians are set to benefit from the price of medicine going down for the first time in over 20 years. From ...

Once-weekly subcutaneous semaglutide 2.4 mg reduced the risk for any hospitalization among adults with obesity and ...

Novo Nordisk’s oral Wegovy gets FDA approval, but rising costs and competition threaten profits. Learn why analysts rate NVO ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

Could the pharmaceutical giant turn things around next year? Let's find out whether Bristol Myers Squibb is a buy, sell, or ...

AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.

Coca-Cola, jokes and mood; some things you really don’t want going flat. But tummies? Arguably always better on the level.

Nodule and lipoma formation can occur rarely after an intramuscular influenza vaccination, particularly when administered ...